Overview
Background
I am the lead of the Effective and Efficient Healthcare program at the Centre for the Business and Economics of Health at The University of Queensland. I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.
I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $45 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.
I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology GroupI, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy, Griffith University
Research interests
-
Economic Evaluation of Healthcare Interventions
-
Health Technology Assessment
-
Value-Based Health Care
-
Cancer Economics
-
Medications use and safety
Research impacts
My research has significantly influenced health policy in Australia and internationally and was pivotal in the allocation of almost $1 billion in new drugs and medical technologies in Australia over the past ten years. My research program about evaluating new health technologies using Value of Information/implementation analyses led to a paradigm shift in the economic evaluation of new interventions and improved patient access to health innovations (e.g., genetic testing, targeted therapies). My research shifted the way clinical trials are prioritised and funded towards a value-based approach, which informed the development of the Australian Clinical Trials Alliance Research Prioritisation Framework.
I have published over 100 peer reviewed articles and technical reports for leading organisations, including 45 technical reports for the Australian Government on the economic evaluation of novel drugs, devices and services for a range of conditions including cancer, genetic testing, cardiovascular disease and liver disease.
Works
Search Professor Haitham Tuffaha’s works on UQ eSpace
2025
Journal Article
Transperineal prostate biopsy under local vs general anaesthesia: a cost-effectiveness analysis
Roberts, Matthew J., Arora, Shiksha, Yao, Henry H., Hogan, Donnacha, Dias, Brendan, O'Connell, Helen E., Wetherell, David, Zargar, Homayoun, Kwok, Michael, McGeorge, Stephen P., Pearce, Adam, Yaxley, John and Tuffaha, Haitham (2025). Transperineal prostate biopsy under local vs general anaesthesia: a cost-effectiveness analysis. BJU international, 1-7. doi: 10.1111/bju.16722
2025
Journal Article
Telehealth-Delivered Exercise to Promote Health after Gynecological Cancer Therapy: A Randomized Waitlist-Controlled Trial
Cunningham, Brent, Porter-Steele, Janine, Hayes, Sandra C., Chiu, Vivian, Clifford, Briana K., Rose, Grace L., Jones, Caroline L., Bailey, Tom G., Young, Leonie, Garrett, Andrea, Nicklin, James, Khan, Asaduzzaman, Tuffaha, Haitham and McCarthy, Alexandra L. (2025). Telehealth-Delivered Exercise to Promote Health after Gynecological Cancer Therapy: A Randomized Waitlist-Controlled Trial. Translational Journal of the American College of Sports Medicine, 10 (2) e000307, 1-6. doi: 10.1249/tjx.0000000000000307
2025
Journal Article
Economic evaluations of non-pharmacological interventions for treating disorders of gut-brain interaction: a scoping review
Pak, Anton, O'Grady, Madeline, Holtmann, Gerald, Shah, Ayesha and Tuffaha, Haitham (2025). Economic evaluations of non-pharmacological interventions for treating disorders of gut-brain interaction: a scoping review. PharmacoEconomics, 43 (3) e14578, 249-269. doi: 10.1007/s40273-024-01455-y
2024
Conference Publication
Developing economic evaluation guidelines for Saudi Arabia – local experts engagement
Maraiki, F., Elhassan, T., Bazarbashi, S., Scuffham, P. and Tuffaha, H. (2024). Developing economic evaluation guidelines for Saudi Arabia – local experts engagement. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17 – 20 November 2024. New York, NY, United States: Elsevier. doi: 10.1016/j.jval.2024.10.2178
2024
Conference Publication
The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers
Teppala, S., Scuffham, P., Edmunds, K., Roberts, M., Fairbairn, D., Smith, D., Horvath, L. and Tuffaha, H. (2024). The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17-20 November 2024. New York, United States: Elsevier. doi: 10.1016/j.jval.2024.10.610
2024
Conference Publication
A roadmap to the use of value of information analysis in health technology assessment: an international study of barriers, facilitators, and potential applications
Grimm, S., Glynn, D., Coyle, D., Jalal, H., Koffijberg, E., Tuffaha, H., Vervaart, M., Welton, N.J., Wilson, E., Rothery, C. and Kunst, N. (2024). A roadmap to the use of value of information analysis in health technology assessment: an international study of barriers, facilitators, and potential applications. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17 – 20 November 2024. New York, NY, United States: Elsevier. doi: 10.1016/j.jval.2024.10.2049
2024
Conference Publication
Prostate cancer survivorship essentials for men with prostate cancer on androgen deprivation therapy: Protocol of an effectiveness-implementation hybrid (type 1) randomised trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study)
Green, Anna, Newton, Rob U., Chambers, Suzanne K., Smith, David P., Tuffaha, Haitham, Galvao, Daniel A., Heathcote, Peter, Patel, Manish I., Christie, David, Egger, Sam, Sara, Sally A. M., Heneka, Nicole and Dunn, Jeff (2024). Prostate cancer survivorship essentials for men with prostate cancer on androgen deprivation therapy: Protocol of an effectiveness-implementation hybrid (type 1) randomised trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study). COSA's 51st Annual Scientific Meeting: Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.14117
2024
Journal Article
The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers
Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Fairbairn, David, Smith, David P., Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. Value in Health, 27 (11), 1515-1527. doi: 10.1016/j.jval.2024.06.019
2024
Conference Publication
The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers
Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew, Fairbairn, David, Smith, David, Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons.
2024
Other Outputs
MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR)
Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR). Canberra, ACT Australia: Commonwealth of Australia.
2024
Conference Publication
Is there sufficient evidence to implement prescribed exercise as standard cancer after-care? Insights to inform resource allocation using the value of information and implementation framework
Wang, Yufan, McCarthy, Sandie and Tuffaha, Haitham (2024). Is there sufficient evidence to implement prescribed exercise as standard cancer after-care? Insights to inform resource allocation using the value of information and implementation framework. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13–15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.
2024
Conference Publication
EV430/#358 Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis
Obermair, Andreas, West, Zoe, Baxter, Eva, Condous, George, Hacker, Neville, Lord, Sally, Mccarthy, Sandie, Janda, Monika, Tuffaha, Haitham, Hayes, Sandi, Disipio, Tracey, Mellon, Anne, Gebski, Val, Mcnally, Orla and Martin, Andrew (2024). EV430/#358 Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis. IGCS 2024 Annual Meeting, Dublin, Ireland, 16-18 October 2024. London, United Kingdom: BMJ Group. doi: 10.1136/ijgc-2024-igcs.551
2024
Journal Article
Modified Oral Health Assessment Tool (M-OHAT) for residential aged care: A co-design protocol
Ferris, Laura J., Ludlow, Kristiana, Walker, Nicole, Georgiou, Andrew, Henry, Julie D., Lopez Silva, Claudia, Ha, Diep H., Stormon, Nicole, Walsh, Laurence J., Ivanovski, Saso, Sexton, Christopher, Silveira Schuch, Helena, Tuffaha, Haitham, Zamora, Angelique, Pritchard, Lyndal and Do, Loc G. (2024). Modified Oral Health Assessment Tool (M-OHAT) for residential aged care: A co-design protocol. Healthcare, 12 (19) 1953, 1-10. doi: 10.3390/healthcare12191953
2024
Conference Publication
Early learnings from a national trial of a consumer and clinician developed survivorship care intervention for men with prostate cancer on androgen deprivation therapy (PCEssentials Hormone Therapy Study)
Green, A., Newton, R. U., Chambers, S., Smith, D. P., Tuffaha, H., Galvao, D. A., Heathcote, P., Patel, M., Christie, D., Egger, S., Sara, S. A., Heneka, N. and Dunn, J. (2024). Early learnings from a national trial of a consumer and clinician developed survivorship care intervention for men with prostate cancer on androgen deprivation therapy (PCEssentials Hormone Therapy Study). World Cancer Congress, Geneva, Switzerland, 17–19 September 2024. Hoboken, NJ, United States: John Wiley & Sons.
2024
Other Outputs
MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation
Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation. Canberra, ACT Australia: Commonwealth of Australia.
2024
Other Outputs
MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia
Hettiarachchi, Ruvini and Tuffaha, Haitham (2024). MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia. Canberra, ACT Australia: Commonwealth of Australia.
2024
Journal Article
A preference-based value framework to assess healthcare provision in an oil and gas industry
Pak, Anton, Pols, Thomas, Kondalsamy-Chennakesavan, Srinivas, McGrail, Matthew, Gurney, Tiana, Fox, Jordan L. and Tuffaha, Haitham (2024). A preference-based value framework to assess healthcare provision in an oil and gas industry. Australian Health Review, 48 (5), 524-529. doi: 10.1071/ah24111
2024
Journal Article
Acceptability of a virtual prostate cancer survivorship care model in rural Australia: A multi-methods, single-centre feasibility pilot
Heneka, Nicole, Chambers, Suzanne K., Schaefer, Isabelle, Carmont, Kelly, Parcell, Melinda, Wallis, Shannon, Walker, Stephen, Tuffaha, Haitham, Steele, Michael and Dunn, Jeff (2024). Acceptability of a virtual prostate cancer survivorship care model in rural Australia: A multi-methods, single-centre feasibility pilot. Australian Journal of Rural Health, 32 (4), 815-826. doi: 10.1111/ajr.13149
2024
Journal Article
The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer
Teppala, Srinivas, Scuffham, Paul A. and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer. International Journal of Technology Assessment in Health Care, 40 (1) e14, 1-9. doi: 10.1017/s0266462324000011
2024
Journal Article
Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study)
Green, Anna, Newton, Robert U, Smith, David P, Tuffaha, Haitham, Galvão, Daniel A, Heathcote, Peter, Patel, Manish I, Christie, David, Egger, Sam, Sara, Sally AM, Heneka, Nicole, Chambers, Suzanne K and Dunn, Jeff (2024). Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study). BMJ Open, 14 (3) e084412, 1-9. doi: 10.1136/bmjopen-2024-084412
Funding
Current funding
Supervision
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program
Principal Advisor
Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds
-
Doctor Philosophy
Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program
Principal Advisor
Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds
-
Doctor Philosophy
Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment
Principal Advisor
Other advisors: Professor Sandie McCarthy
Completed supervision
-
2024
Doctor Philosophy
Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment
Principal Advisor
Other advisors: Professor Sandie McCarthy
Media
Enquiries
Contact Professor Haitham Tuffaha directly for media enquiries about:
- Cancer Economics
- Health Economics
- Health Services Research
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: